Aurobindo Pharma shares gained 2% on Monday morning after a US-based unit, Aurolife Pharma, cleared an FDA plant inspection with VAI status. The gain follows...
Under the futures and options (F&O) segment, four stocks were banned from trade on Monday, 17 August, by the National Stock Exchange (NSE). The securities...
Shukra Pharma signed a Term Sheet with Singapore’s Borns Medical Robotics to build AI surgical robotic systems for India and APAC. The proposed venture will...
The DDA has approved the Master Plan for Delhi 2047, setting a long-term growth roadmap for the capital over the next two decades. Lieutenant Governor...